The role of mineral metabolism and inflammation on dialysis vascular access failure

Archive ouverte

Morena, Marion | Bosc, Jean-Yves | Jaussent, Isabelle | Dupuy, Anne-Marie | Terrier, Nathalie | Leray-Moragues, Hélène | Flavier, Jean-Louis | Maurice, François | Delcourt, Cécile | Cristol, Jean-Paul | Canaud, Bernard

Edité par CCSD -

Thrombosis of arteriovenous fistula (AVF) is the leading cause of vascular access (VA) loss usually due to silent stenosis. Therefore, assessment of relevant risk factors of VA monitoring may provide insight into potential therapeutic targets for stenosis and thrombosis. The aim of this study was to evaluate the influence of cardiovascular risk factors (including inflammation and mineral metabolism dysfunctions) on the failure of internal AVF in HD patients. 128 HD patients with internal AVF were included in the study and followed up for two years. At baseline, VA morphology and function were followed by Doppler ultrasonography and serum albumin, prealbumine, C-reactive protein, orosomucoid, calcium, phosphorus, parathyroid hormone, bone-type alkaline phosphatase, osteoprotegerin and receptor activator of nuclear factor k B ligand were measured. At baseline, 50 stenoses were detected but none of them required any intervention. Age and biological parameters did not significantly differ between patients with or without VA stenosis. Over the two year- follow-up, VA thrombosis occurred in 19 patients. Preexisting stenosis of VA was present in 9/19 patients (47.3 % of cases) (chi-square=3.708, p=0.0538). Despite the low rate of events, phosphorus [1.75(0.95-2.77) vs 1.42(0.47-3.22) mmol/L, p=0.0416], CalciumxPhosphorus product [4.00(2.00-5.90) vs 3.40(1.10-6.80) mmol2/L2, p=0.0676] and parathyroid hormone [165.00(1.00-944.00) vs 79.50(1.00-846.60) ng/L, p=0.0814) levels were higher in the 19 thrombotic patients whereas all other biological parameters did not significantly differ. These results, which confirm that VA thrombosis occurs more frequently upon preexisting stenosis, also demonstrate that mineral metabolism disorders, compared to inflammation, may contribute to VA dysfunction leading to thrombosis.

Suggestions

Du même auteur

Plasma osteoprotegerin is associated with mortality in hemodialysis patients.

Archive ouverte | Morena, Marion | CCSD

Expression of bone proteins resulting from transdifferentiation of vascular smooth muscle cells into osteoblasts suggests that vascular calcifications are a bioactive process. Regulating molecules such as osteoprotegerin (OPG) and...

Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination. Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination: aminothiols as predictive factors of hemodialysis outcome

Archive ouverte | Badiou, Stéphanie | CCSD

Background: Controversial results about hyperhomocysteinemia and cardiovascular (CV) risk in hemodialysis (HD) could be due in part to the methodology used for homocysteine (Hcy) determination. Objective: To compare the influence ...

Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.: Nutritional indices of mortality in HD

Archive ouverte | Terrier, Nathalie | CCSD

BACKGROUND: Malnutrition and inflammation are recognized as important predictors of poor clinical outcome in haemodialysis (HD). This study was designed to estimate the relative contribution of known biological markers of inflamma...

Chargement des enrichissements...